Breaking News Headlines Today

News about Biotech

Stay current with all the latest and breaking news about Biotech, compare headlines and perspectives between news sources on stories happening today. In total, 114 stories have been published about Biotech which Ground News has aggregated in the past 3 months.

Covered Most By

stocktitan.net

Unknown

DirectorsTalk Interviews

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Biotech News

Money · Germany

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Coverage: 2 sources

AI, Armor, Biotech: According to a study, German start-ups are receiving more money from investors. In addition to Berlin, Bavaria is becoming the second pillar of the founding industry.See the Story

Biotech · England

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Investment led by GMC Life Sciences Fund by PXN Ventures and NPIF II – PXN Equity Finance See the Story

Marriott International

Top Hotel Stocks To Research – January 19th

Marriott International, Hilton Worldwide, Las Vegas Sands, MGM Resorts International, Host Hotels & Resorts, Choice Hotels International, and Hyatt Hotels are the seven Hotel stocks to watch today, according to MarketBeat’s stock screener tool. Hotel stocks are shares of publicly traded companies that own, operate, manage or franchise hotels and other lodging properties, including hotel […]See the Story

How Dr. Marek Polák Is Fixing One of Biotech’s Most Expensive Bottlenecks

100% Left coverage: 1 sources

We all know someone waiting on a medical breakthrough. It could be a parent battling a chronic illness, a colleague pushing through long workdays while managing treatment, or a child whose options have not changed in decades. And while the human cost is clear, there is also a business cost that is just as real. Slow drug development pulls people out of the workforce, raises insurance premiums, and forces companies to absorb productivity losses t…Biotech · United States Read Article

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Investment led by GMC Life Sciences Fund by PXN Ventures and NPIF II – PXN Equity FinanceBiotech · England See the Story

Top Hotel Stocks To Research – January 19th

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Coverage: 2 sources

AI, Armor, Biotech: According to a study, German start-ups are receiving more money from investors. In addition to Berlin, Bavaria is becoming the second pillar of the founding industry.Money · Germany See the Story

Cel-Sci Corporation (CVM) Stock Analysis: Exploring A 751% Upside Potential In Biotech

Cel-Sci Corporation (NASDAQ: CVM) is capturing investor attention with its ambitious approach to cancer treatment and a staggering potential upside of 751.70%, according to analyst ratings. This clinical-stage biotechnology company, headquartered in Vienna, Virginia, is focused on harnessing the immune system to combat cancer and other diseases. Its lead product, Multikine, has shown promise in Phase III clinical trials for the treatment of cert…Biotech · Vienna Read Article

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech With 94.53% Potential Upside

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is making waves in the biotechnology sector with its promising pipeline focused on central nervous system (CNS) disorders. With a market capitalization of $1.28 billion, this company is capturing the interest of investors, especially given its substantial potential upside of 94.53%, as indicated by recent analyst ratings. Specializing in…Biotech · Boston Read Article

Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition

Venture capital firms at the J.P. Morgan Healthcare Con […] The post Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition first appeared on GeneOnline News. The post Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition appeared first on GeneOnline News.Biotech · San Francisco See the Story

Crossroads of Capital, Capacity, and Caution - SwissCognitive AI Investment Radar

From $1B drug labs to $3T data forecasts, this week’s AI investment landscape reveals an ecosystem increasingly grounded in infrastructure, long-term planning, and sector diversification. Crossroads of Capital, Capacity, and Caution – SwissCognitive AI Investment Radar Pharma and biotech made a strong entrance into 2026, with Nvidia and Eli Lilly committing $1 billion to an AI drug discovery lab, and AstraZeneca acquiring Modella AI to reinf…Pharma · Switzerland Read Article

98% of the Drugs Blocked: This Brain Lock that a French Biotech Wants to Blow Up

An innovation of rupture in neurodegenerative diseases: Harmonix develops a focused ultrasonic solution to treat Alzheimer and Parkinson. The Orléanian start-up has just been selected by the Servier laboratory to integrate its Paris Saclay incubator. It aims to market its solution by 2028. Explanations.Alzheimer's Disease · Orléans Read Article

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too (INBX)

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science background to generate long term value from Healthcare. He is the author of the investing group Biotech Analysis Central which contains a library of 600+ Biotech investing articles, a model portfolio of 10+ small and mid-cap stocks with deep analysis for each, live chat, and a range of analysis…Biotech · United Kingdom Read Article

News about Biotech

News about Biotech

Covered Most By

Local News Publishers

Top Biotech News

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Top Hotel Stocks To Research – January 19th

How Dr. Marek Polák Is Fixing One of Biotech’s Most Expensive Bottlenecks

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Top Hotel Stocks To Research – January 19th

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Cel-Sci Corporation (CVM) Stock Analysis: Exploring A 751% Upside Potential In Biotech

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech With 94.53% Potential Upside

Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition

Crossroads of Capital, Capacity, and Caution - SwissCognitive AI Investment Radar

98% of the Drugs Blocked: This Brain Lock that a French Biotech Wants to Blow Up

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too (INBX)

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Biotech

How Dr. Marek Polák Is Fixing One of Biotech’s Most Expensive Bottlenecks

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Top Hotel Stocks To Research – January 19th

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Cel-Sci Corporation (CVM) Stock Analysis: Exploring A 751% Upside Potential In Biotech

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech With 94.53% Potential Upside

Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition

Crossroads of Capital, Capacity, and Caution - SwissCognitive AI Investment Radar

98% of the Drugs Blocked: This Brain Lock that a French Biotech Wants to Blow Up

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too (INBX)

News about Biotech

News about Biotech

Covered Most By

Local News Publishers Too Big Arrow Icon

Top Biotech News

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Top Hotel Stocks To Research – January 19th

How Dr. Marek Polák Is Fixing One of Biotech’s Most Expensive Bottlenecks

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Top Hotel Stocks To Research – January 19th

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Cel-Sci Corporation (CVM) Stock Analysis: Exploring A 751% Upside Potential In Biotech

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech With 94.53% Potential Upside

Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition

Crossroads of Capital, Capacity, and Caution - SwissCognitive AI Investment Radar

98% of the Drugs Blocked: This Brain Lock that a French Biotech Wants to Blow Up

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too (INBX)

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Biotech

How Dr. Marek Polák Is Fixing One of Biotech’s Most Expensive Bottlenecks

Biotech firm secures £4.5m funding to take ‘world-first’ implantable treatment for brain cancer to clinics

Top Hotel Stocks To Research – January 19th

Start-Ups Get 2025 More Money - Bavaria Ahead of Berlin

Cel-Sci Corporation (CVM) Stock Analysis: Exploring A 751% Upside Potential In Biotech

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech With 94.53% Potential Upside

Venture Capital Firms at J.P. Morgan Healthcare Conference Focus on Leadership Evaluation Amid Funding Challenges and Chinese Market Competition

Crossroads of Capital, Capacity, and Caution - SwissCognitive AI Investment Radar

98% of the Drugs Blocked: This Brain Lock that a French Biotech Wants to Blow Up

Inhibrx: Ozekibart Beyond Chondrosarcoma, With Other Targeted Indications, Too (INBX)

Local News Publishers